Achieving a balance between mucus penetration and cell uptake is still challenging because the neutral, hydrophilic surfaces that benefit mucus penetration can limit interactions with epithelial cells unless they incorporate features such as positive charges or targeting molecules
During a median follow-up of 5.4 years the renal outcome developed in 17.1% of patients in the dulaglutide group and 19.6% of patients in the placebo group (HR 0.85, p=00004)
Sources: All pricing data sourced from manufacturer websites (Novo Nordisk, Eli Lilly), government agencies (CMS, FDA, CBO), insurer formularies (UHC, Cigna, Aetna, Anthem), pharmacy pricing platforms (GoodRx, Costco), and policy research organizations (KFF, ICER)
As your body adapts over 4-8 weeks, many patients experience natural improvement in bowel regularity without intervention